EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management

Karthik Mangu, Aashna Nimish Gandhi, Md Rizwanullah

Pathology - Research and Practice · 2026-01 · 277 · 156308

DOI: 10.1016/j.prp.2025.156308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-01. Verfasst von Karthik Mangu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kognovate Education and Research, Bionest, Avishkaran (NIPER), Hyderabad, Telangana 500037, India. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Antineoplastic Agents, Hormonal, Drug Delivery Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 185 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) remains a major cause of cancer-related mortality among women worldwide, with estrogen receptor-positive (ER+) tumors representing the most common subtype. Tamoxifen (TMX), a selective estrogen receptor modulator, has been a cornerstone in ER+ BC therapy for decades. However, its clinical utility is hampered by its high lipophilicity, poor water solubility, systemic toxicity, off-target effects, and the emergence of resistance. In recent years, nanoparticle (NPs)-based drug delivery has emerged as a promising approach to surmount these challenges and enhance the therapeutic potential of TMX. These NPs not only improve solubility and bioavailability but also demonstrate validated outcomes such as resistance reversal, prolonged plasma half-life, significant tumor inhibition, and reduced systemic toxicity, thereby underscoring their clinical-translational potential in BC. This review critically analyzes the limitations of traditional TMX therapy and critically evaluates the role of various NPs-based strategies in overcoming these barriers. Furthermore, we explored the potential of multifunctional NPs to co-deliver TMX with other therapeutic agents to achieve synergistic effects and circumvent resistance. Overall, this review highlights the transformative potential of NPs-enabled TMX delivery systems and provides future perspectives on their clinical translation for better BC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsAntineoplastic Agents, HormonalDrug Delivery SystemsSelective Estrogen Receptor ModulatorsHumansFemaleNanotechnologyNanoparticlesAnimalsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Breast cancerNanoparticlesOral bioavailabilityTamoxifenTamoxifen resistanceTumor targeting

Substanzen

TamoxifenAntineoplastic Agents, HormonalSelective Estrogen Receptor Modulators

Autor:innen und Institutionen

  • Kognovate Education and Research, Bionest, Avishkaran (NIPER), Hyderabad, Telangana 500037, India.
  • Emirates International Schools - Jumeirah, Al Thanya Street, Dubai 6446, United Arab Emirates.
  • Kognovate Education and Research, Bionest, Avishkaran (NIPER), Hyderabad, Telangana 500037, India. Electronic address: mdrizwanullah54@gmail.com.

Zitieren

APA

Mangu, K., Gandhi, A. N., & Rizwanullah, M. (2026). Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management. Pathology - Research and Practice, 277, 156308. https://doi.org/10.1016/j.prp.2025.156308

Vancouver

Mangu K, Gandhi AN, Rizwanullah M. Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management. Pathology - Research and Practice. 2026;277:156308. doi:10.1016/j.prp.2025.156308

BibTeX
@article{Mangu2026,
  author = {Mangu, Karthik and Gandhi, Aashna Nimish and Rizwanullah, Md},
  title = {Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management},
  journal = {Pathology - Research and Practice},
  year = {2026},
  volume = {277},
  pages = {156308},
  doi = {10.1016/j.prp.2025.156308}
}
Kostenlos starten →